How a Tiny Island Nation Could Use Cannabis to Disrupt Diabetes Care

How a Tiny Island Nation Could Use Cannabis to Disrupt Diabetes Care
November 15, 2018 Ryan Shatto
In News Articles

CMW Client Phoenix Life Sciences was featured in an article from Leafly involving their work in diabetes care and treatment.

Next year, Denver-based CBD producer Phoenix Life Sciences International plans to conduct a series of short-term studies with Vanuatu patients using US-imported CBD as a diabetes treatment, beginning with a 1,000-person trial at the country’s main hospital. While the cannabis will be imported at first, Phoenix is also on track to break ground in 2019 on its international cannabis-production hub and 50 acres of growing land on a former military base in Vanuatu, a site now reportedly being “readied” by goats.

Read the FULL ARTICLE HERE

Comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

*